New nasal spray could offer fast relief for dangerous heart rhythms
Disease control
Not yet recruiting
This study is testing whether a nasal spray called etripamil can safely and quickly lower a dangerously fast heart rate during episodes of atrial fibrillation (AFib). About 750 adults with a history of symptomatic AFib will be given either the real spray or a placebo to use at ho…
Phase: PHASE3 • Sponsor: Milestone Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC